MedTrace Logo

Prevalence of Delayed Chemotherapy Associated Nausea

NCT04342780 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 172

Last updated 2024-04-19

No results posted yet for this study

Summary

This study evaluates the prevalence of delayed chemotherapy induced nausea in adult oncology patients in real clinical practice of day clinics.

Conditions

  • Chemotherapy-induced Nausea and Vomiting

Sponsors & Collaborators

  • ZETUP St. Gallen

    collaborator UNKNOWN

  • Dr.-Hans-Altschüler-Stiftung

    collaborator UNKNOWN

  • University Medical Center Freiburg

    collaborator OTHER

  • Spital Thurgau AG

    collaborator OTHER

  • Antje Koller

    lead OTHER

Principal Investigators

  • Antje Koller · Ostschweizer Fachhochschule St. Gallen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-29
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04342780 on ClinicalTrials.gov